| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2023 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 40,000 | $51.75 | $2,070,011.86 | -39.6% | +17.4% | +13.6% | |
| Jun 21, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 603 | $1.48 | $894.25 | -0.9% | -12.4% | +61.8% | |
| Jun 21, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 31,454 | $454.13 | $14,284,313.01 | - | +26.9% | +95.6% | |
| Jun 20, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 10,707 | $8.55 | $91,544.85 | -79.6% | -24.1% | +168.1% | |
| Jun 20, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 34,156 | $454.08 | $15,509,556.48 | - | +26.4% | +96.0% | |
| Jun 20, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 21,741 | $8.55 | $185,885.55 | -11.5% | -24.1% | +168.1% | |
| Jun 16, 2023 | AYTU Aytu Biopharma, Inc | Pyszczymuka Greg | Chief Commerical Officer | Buy | 12,000 | $1.87 | $22,428.00 | +120.8% | -15.9% | +56.6% | |
| Jun 16, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 25,015 | $455.50 | $11,394,291.92 | - | +32.1% | +96.2% | |
| Jun 16, 2023 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 566 | $8.95 | $5,065.70 | -4.0% | -27.2% | +174.6% | |
| Jun 16, 2023 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 14,271 | $9.01 | $128,650.21 | -7.0% | -27.2% | +174.6% | |
| Jun 16, 2023 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO And President | Sell | 60,000 | $20.86 | $1,251,726.98 | -22.0% | -83.0% | -93.2% | |
| Jun 15, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 27,353 | $454.15 | $12,422,247.76 | - | +31.9% | +93.5% | |
| Jun 15, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, EVP &Treasurer | Sell | 36,868 | $50.85 | $1,874,789.72 | -9.4% | -11.4% | -22.5% | |
| Jun 15, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $227.77 | $1,366,634.23 | -7.4% | -3.2% | +25.5% | |
| Jun 15, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 5,000 | $51.79 | $258,946.50 | -4.9% | -11.4% | -22.5% | |
| Jun 15, 2023 | LLY Eli Lilly & Co | Norton Johna | EVP, Global Quality | Sell | 3,294 | $446.15 | $1,469,601.63 | -5.1% | +31.9% | +93.5% | |
| Jun 15, 2023 | BCRX Biocryst Pharmaceuticals Inc | Sanders MacHelle45 | Director | Sell | 4,000 | $7.98 | $31,920.00 | -13.5% | -13.8% | -22.7% | |
| Jun 14, 2023 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Senior Vice President, Finance | Sell | 6,366 | $38.42 | $244,606.45 | -7.9% | -12.8% | -26.8% | |
| Jun 14, 2023 | AYTU Aytu Biopharma, Inc | Disbrow Joshua R.57 | Chief Executive Officer | Buy | 14,000 | $1.86 | $26,079.20 | +24.3% | -7.4% | +64.0% | |
| Jun 14, 2023 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | Chief Administrative Officer | Sell | 6,467 | $37.03 | $239,473.01 | -20.3% | -12.8% | -26.8% | |
| Jun 14, 2023 | DVAX Dynavax Technologies Corp | Hack Andrew A. F.62 | Director | Sell | 500,000 | $12.68 | $6,340,000.00 | -17.2% | +7.1% | -4.8% | |
| Jun 14, 2023 | BCRX Biocryst Pharmaceuticals Inc | Hutson Nancy J58 | Director | Sell | 12,866 | $8.04 | $103,442.64 | -13.6% | -12.6% | -21.5% | |
| Jun 13, 2023 | PRGO Perrigo Co Plc | Parker Geoffrey M.46 | Director | Buy | 10,000 | $33.06 | $330,637.00 | +63.0% | +3.1% | -15.9% | |
| Jun 13, 2023 | TLLTF Tilt Holdings Inc. | Conder Timothy Alan | Interim CEO | Buy | 75,000 | $0.04 | $3,000.00 | +5.4% | - | - | |
| Jun 13, 2023 | TKNO Alpha Teknova, Inc. | Hood Lisa54 | Chief People Officer | Sell | 11,400 | $3.80 | $43,267.56 | -25.2% | -54.0% | -55.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.